Phase II Randomized Controlled Trial Evaluating Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07471230

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:13.544220+00:00

Published At

2026-03-13T00:00:00+00:00

Record Updated At

2026-03-13

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Parkinsonism or Parkinson\u0027s Disease Nos", "Parkinsonism in Diseases Classified Elsewhere"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-13"

protocolSection.identificationModule.nctId

"NCT07471230"

protocolSection.identificationModule.officialTitle

"Phase II Randomized Controlled Trial Evaluating Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Parkinsonism or Parkinson's Disease Nos (protocolSection.conditionsModule.conditions)
• Parkinsonism in Diseases Classified Elsewhere (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.